Cellcept (mycophenolate mofetil) and Myfortic (mycophenolic acid) - Important Safety Information from Roche Products (Ireland) Ltd. and Novartis Ireland Ltd. as approved by the Health Products Regulatory Authority

Notice type: 3rd Party Publications

Date: 16/12/2014

Important Safety Information communication from Roche Products (Ireland) Ltd. and Novartis Ireland Ltd. on new warning about the risks of hypogammaglobulinaemia and bronchiectasis with Cellcept (mycophenolate mofetil) and Myfortic (mycophenolic acid).

Important Safety Information - Cellcept (mycophenolate mofetil) and Myfortic  (mycophenolic acid)